EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pivotal Trials in Heart Failure in 2024—Putting Evidence into Clinical Practice!

Prashant Thandi iD, Akshyaya Pradhan iD, Suresh Kumar Behera

International Journal of Angiology · 01.03.2026 · 35 (01) · 001-009

DOI: 10.1055/a-2624-5735 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Angiology, erschienen am 01.03.2026. Verfasst von Prashant Thandi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intricate interplay of physiological, psychological, and social factors presents considerable challenges in addressing heart failure. It is imperative to comprehend the epidemiology and pathophysiology, identify predictors and their influence on clinical outcomes, and effectively utilize the diagnostic tools. Such evidence is vital for formulating innovative therapeutic strategies to decelerate the growing heart failure epidemic. As of 2024, the field of heart failure has witnessed significant advancements in therapies applicable to both heart failure with preserved and reduced ejection fraction. Recent studies in this domain yielded valuable insights into the latest developments in cardiovascular medicine, which possess the potential to revolutionize treatment strategies. These advancements advocate for a more integrated approach to patient care and aim to enhance overall clinical outcomes. Below is a concise overview of key studies showcased at scientific meetings over the past year, which promise to improve heart failure management.

Schlagwörter

Stichwörter der Autor:innen

diabetic cardiomyopathyempaglifozinfinerenoneheart failurenon-obstructive HCMobesitysemaglutide

Autor:innen und Institutionen

  • Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Department of Cardiology, Siksha 'O' Anusandhan, Institute of Medical Sciences & SUM Hospital, Bhubaneswar, Odisha, India.

ORCID-Profile: Prashant Thandi, Akshyaya Pradhan

Zitieren

APA

Thandi, P., Pradhan, A., & Behera, S. K. (2026). Pivotal Trials in Heart Failure in 2024—Putting Evidence into Clinical Practice!. International Journal of Angiology, 35(01), 001-009. https://doi.org/10.1055/a-2624-5735

Vancouver

Thandi P, Pradhan A, Behera SK. Pivotal Trials in Heart Failure in 2024—Putting Evidence into Clinical Practice!. International Journal of Angiology. 2026;35(01):001-009. doi:10.1055/a-2624-5735

BibTeX
@article{Thandi2026,
  author = {Thandi, Prashant and Pradhan, Akshyaya and Behera, Suresh Kumar},
  title = {Pivotal Trials in Heart Failure in 2024—Putting Evidence into Clinical Practice!},
  journal = {International Journal of Angiology},
  year = {2026},
  volume = {35},
  number = {01},
  pages = {001--009},
  doi = {10.1055/a-2624-5735}
}
Kostenlos starten →